Sanofi researchers are developing potentially transformative therapies to help improve outcomes and impact the lives of people living with many different types of cancer, including skin, blood, breast and lung cancers.

Sanofi is developing potential new medicines for many chronic dermatologic, respiratory, and gastrointestinal diseases. These include type 2 inflammatory diseases such as asthma, atopic dermatitis, eosinophilic esophagitis, chronic obstructive pulmonary disease, and others.

Sanofi's clinical research teams are working relentlessly to improve the lives of millions of people worldwide living with neuro-degenerative diseases. Our researchers are committed to accelerating the development of potential treatments for multiple sclerosis, amyotrophic lateral sclerosis, and other neurological diseases.

Some of the most serious unmet patient needs today are in the field of hematology. Sanofi researchers are dedicated to breaking barriers in rare blood disease research. The goal of our studies is to improve the health and lives of people with rare blood disorders around the world.

There are more than 7,000 different rare diseases, which affect more than 350 million people around the world. These uncommon, underserved medical conditions are often difficult to diagnose and treat. Patients can endure a long journey involving specialty doctors, tests, and misdiagnoses.

Sanofi aims to protect people around the world from severe infectious diseases, at every stage of life. Our vaccine teams are working harder than ever before to develop vaccines and other types of immunization to improve public health and well-being.